Company Analysis

Innoviva, Inc. (INVA)

Nasdaq: INVA · Pharmaceutical Preparations · Burlingame, CA · filing with the SEC since 2000
Grade6.2
◀ Past 6.4● Present 6.5▶ Future 5.7

Who runs Innoviva, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Raifeld Pavel
Chief Executive Officer. First filing May 2020, latest Aug 24, 2026, 1 filing in all.
Officers reporting now
3
of 8 people with a filing in the last fifteen months
Directors reporting now
5
27 people on the record since 2006
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Raifeld PavelChief Executive OfficerMay 2020Aug 24, 2026none
Basso StephenChief Financial OfficerAug 2023Aug 24, 2026none
Zhen MarianneChief Accounting OfficerAug 2018Aug 24, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Linden JosephinedirectorMay 2026May 20, 2026none
Dipaolo MarkdirectorFeb 2018May 6, 2026none
Haimovitz JulesdirectorFeb 2018May 6, 2026none
Schlesinger Sarah J.directorFeb 2018May 6, 2026none
Small Derek AdirectorMay 2024May 6, 2026none
Earlier names on the record22, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton INVA · research, not advice